Point72 Asia (Singapore)’s Lyra Therapeutics LYRA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-114	Closed	-$35.5K	–	1302
2024 Q1	$35.5K	Buy	114 +101	+777%	+$31.5K	0.01%	873
2023 Q4	$3.42K	Buy	+13	New	+$3.42K	﹤0.01%	545